New pill combo shows promise for tough brain cancer
NCT ID NCT03328078
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental oral drug called emavusertib (CA-4948), taken alone or with ibrutinib, in adults with relapsed or refractory primary central nervous system lymphoma (PCNSL). The trial has multiple parts to find the safest dose and see if the drug shrinks tumors. About 152 participants will be enrolled across several centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Emavusertib (also called CA-4948) taken as a tablet, alone or with another drug called ibrutinib.
What this could lead to
If successful, this could offer a new oral treatment option for patients with a hard-to-treat brain lymphoma that has come back or not responded to other therapies.
What could go wrong
This is an early-phase trial (Phase 1/2) with a small number of participants, so the drug may not work as hoped or could have serious side effects. It is not yet proven to be safe or effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Columbia University Irving Medical Center
WITHDRAWNNew York, New York, 10032, United States
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Duke University Medical Center, Duke Cancer Center
RECRUITINGDurham, North Carolina, 27710, United States
-
Fred and Pamela Buffett Cancer Center
RECRUITINGOmaha, Nebraska, 68198, United States
-
Hackensack University Medical Center
COMPLETEDHackensack, New Jersey, 07601, United States
-
Hadassah Medical Center / Ein-Carem
RECRUITINGJerusalem, Israel
-
Hematology Department Soroka UMC / Heanatology Department
RECRUITINGBeersheba, Israel
-
Hopital de la Timone
RECRUITINGMarseille, France
-
Hospital Pitie Salpetriere
RECRUITINGParis, France
-
Hospital Universitario Virgen del Rocio
RECRUITINGSeville, Spain
-
Hospital of the University of Pennsylvania
COMPLETEDPhiladelphia, Pennsylvania, 19104, United States
-
Huntsman Cancer Institute, University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
-
IRCCS San Raffaele Scientific Institute
RECRUITINGMilan, Italy
-
IRST - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
RECRUITINGMeldola, Italy
-
Institut Bergonie
RECRUITINGBordeaux, France
-
Institut Curie Hospital
RECRUITINGParis, France
-
MD Anderson Cancer Center Madrid
RECRUITINGMadrid, Spain
-
Mayo Clinic
COMPLETEDPhoenix, Arizona, 85054, United States
-
Mayo Clinic
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Mt Sinai
RECRUITINGNew York, New York, 10029, United States
-
NarodowyInstytutu Onkologii im. Marii Sklodowskiej-Curie-Panstwowy Instytutu Badawczy
RECRUITINGWarsaw, Poland
-
Northwestern Memorial Hospital
RECRUITINGChicago, Illinois, 60611, United States
-
Oddzial Kliniczny Hematologii
WITHDRAWNKrakow, Poland
-
Providence Neurological Specialties West
RECRUITINGPortland, Oregon, 97225, United States
-
Providence St. John's Health Center
RECRUITINGSanta Monica, California, 90404, United States
-
Rambam Medical Center
RECRUITINGHaifa, Israel
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14263, United States
-
SODc Ematologia Azienda Ospedaliera Universitaria Careggi
RECRUITINGFlorence, Italy
-
Smilow Cancer Hospital at Yale-New Haven
COMPLETEDNew Haven, Connecticut, 06510, United States
-
St. Joseph's Hospital and Medical Center
RECRUITINGPhoenix, Arizona, 85013, United States
-
Swedish Cancer Institute
COMPLETEDSeattle, Washington, 98104, United States
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
UCLA Department of Medicine - Hematology/Oncology
WITHDRAWNSanta Monica, California, 90404, United States
-
UPMC Hilman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
UT Southwestern Medical Center
ACTIVE_NOT_RECRUITINGDallas, Texas, 75235, United States
-
University Hospital Vall d'Hebron
RECRUITINGBarcelona, Spain
-
University of Tennessee Medical Center
COMPLETEDKnoxville, Tennessee, 37920, United States
-
University of Washington Medical Center
RECRUITINGSeattle, Washington, 98195, United States
-
Università di Torino Croce e Carle
RECRUITINGCuneo, Italy
-
Uniwersyteckie Centrum Kliniczne Osrodek Badan Klinicznych Wczesnych Faz
RECRUITINGGdansk, Poland
-
Všeobecná fakultní nemocnice v Praze
RECRUITINGPrague, Czechia